Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Kuroiwa

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|June 4, 2025
Gene signatures associated with brain-topical proliferative activity in breast cancerYuka Kuroiwa, Yuta Doi, Kazuya Nakamichi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|February 17, 2024
Analysis of the responsiveness to antiandrogens in multiple breast cancer cell linesYuka Kuroiwa, Kagenori Ito, Jun Nakayama, et al.
International Journal of Molecular Sciences|March 6, 2021
The In Vivo Selection Method in Breast Cancer MetastasisJun Nakayama, Yuxuan Han, Yuka Kuroiwa, et al.
Cancers|July 10, 2020
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell LinesYuka Kuroiwa, Jun Nakayama, Chihiro Adachi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|June 4, 2025
Gene signatures associated with brain-topical proliferative activity in breast cancerYuka Kuroiwa, Yuta Doi, Kazuya Nakamichi, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|February 17, 2024
Analysis of the responsiveness to antiandrogens in multiple breast cancer cell linesYuka Kuroiwa, Kagenori Ito, Jun Nakayama, et al.
International Journal of Molecular Sciences|March 6, 2021
The In Vivo Selection Method in Breast Cancer MetastasisJun Nakayama, Yuxuan Han, Yuka Kuroiwa, et al.
Cancers|July 10, 2020
Proliferative Classification of Intracranially Injected HER2-positive Breast Cancer Cell LinesYuka Kuroiwa, Jun Nakayama, Chihiro Adachi, et al.
Pageof 1